Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

    NEXT STORY
    Global Sports Medicine Markets to 2024 – An $8.8 Billion Opportunity, Rising at a CAGR of 6%
    PREV STORY
    Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Chembio Diagnostics Appoints Christine Rousseau, Ph.D. as Vice President, Corporate Development

    MEDFORD, N.Y., July 19, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

    author_avatar
    NASDAQ Market News

    Inovio’s Zika Vaccine Selected As 2016 Technology Breakthrough

    PLYMOUTH MEETING, Pa., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

    author_avatar
    NASDAQ Market News

    AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma

    author_avatar
    NASDAQ Market News